Powered by
ANN ARBOR—Kraig Biocraft Laboratories Inc. (OTCQB: KBLB), the developer of high-strength fibers and textiles using genetically engineered silkworms, announced that its COO, Jon Rice, will travel to Vietnam this week …
ANN ARBOR—Kraig Biocraft Laboratories Inc. (OTCQB: KBLB), the Ann Arbor-based developer of advanced fibers and textiles through genetic engineering, has named Julie Bishop and Anurag Gupta to its expanded board …
ANN ARBOR—Kraig Biocraft Laboratories Inc. (OTCQB: KBLB) Thursday announced the completion of construction at its new biotech research laboratory in Vietnam. The Ann Arbor-based company, which has spliced spider genes …
ANN ARBOR—Officials at Kraig Biocraft Laboratories Inc. (OTC: KBLB) announced Monday that its shareholders voted at their annual meeting July 24 to approve uplisting the company’s stock to a national …
ANN ARBOR—Kraig Biocraft Laboratories Inc. (OTCQB: KBLB), a biotechnology company using genetically engineered silkworms to create super-strong fibers and fabrics, announced the next generation of its genetically engineered “spider silk” …
ANN ARBOR—Kraig Biocraft Laboratories Inc. (OTCQB: KBLB) announced that it had filed five new provisional patent applications for technologies related to its recombinant spider silk technologies. These applications cover a …
ANN ARBOR—Kraig Biocraft Laboratories Inc. (OTCQB: KBLB), the developer of “spider silk” textiles through genetic engineering, announced that its subsidiary Prodigy Textiles has signed a new five-year lease on a …
ANN ARBOER—Kraig Biocraft Laboratories Inc. (OTC: KBLB) announced that Polartec, the Andover, Mass.-based advanced fabric manufacturer, would bring to market the first fabrics made from Kraig’s “spider silk” technologies. Kraig …
ANN ARBOR – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) announced a new agreement with one of its early research and financing partners, the University of Notre Dame, that converts part …
ANN ARBOR – Officials at Kraig Biocraft Laboratories Inc. (OTC: KBLB) announced that the company had closed a $1 million round of private financing to fund expansion of its recombinant …